Context Therapeutics Inc.

Historical 13F Holders

Symbol
CNTX
CUSIP
21077P108
All holders as of
Q2 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Filings

13D/G Filers

Investors who own more than 5% of a class must file a Schedule 13D or 13G. Each filer's latest filing for 21077P108 since 12/18/2024, largest first.

Filer % of Class Filed
Avidity Partners Management LP 13G/A
8.7% 5/12/2026
Event 3/31/2026
Deep Track Capital, LP 13G/A
8.3% 5/15/2025
Event 3/31/2025
Soleus Capital Master Fund, L.P. 13G/A
7.6% 5/8/2026
Event 3/31/2026
BlackRock, Inc. 13G 6.7% 7/27/2026
Event 6/30/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Franklin Resources, Inc. 13G/A
4.5% 5/9/2025
Event 3/31/2025
Octagon Capital Advisors LP 13G/A
3.3% 7/31/2026
Event 6/30/2026
Blue Owl Capital Holdings LP 13G/A 3.2% 8/12/2026
Event 6/30/2026
Great Point Partners, LLC 13G/A
2.4% 5/15/2026
Event 3/31/2026
Lehr Martin A. 13G/A
2.1% 2/12/2025
Event 12/31/2024
MPM BioImpact LLC 13G/A 1.4% 8/14/2026
Event 6/30/2026
Opaleye Management Inc. 13G/A 0% 2/14/2025
Event 12/31/2024

13F Holders by Quarter

Period Filings Shares, Excl. Options Value, Excl. Options
2026 Q3 2 6.98 k $2.10 k
2026 Q2 79 62.8 M $34.8 M
2026 Q1 63 79.3 M $206 M
2025 Q4 44 65.3 M $96.0 M
2025 Q3 37 69.0 M $66.8 M
2025 Q2 40 68.6 M $45.0 M
2025 Q1 43 71.4 M $43.7 M
2024 Q4 53 72.8 M $76.4 M
2024 Q3 44 56.7 M $111 M
2024 Q2 36 59.0 M $118 M
2024 Q1 27 3.94 M $5.43 M
2023 Q4 26 3.56 M $4.02 M
2023 Q3 24 2.58 M $3.89 M
2023 Q2 23 2.24 M $3.58 M
2023 Q1 23 1.29 M $723 k
2022 Q4 26 3.92 M $2.57 M
2022 Q3 25 4.13 M $4.59 M
2022 Q2 21 3.64 M $6.32 M
2022 Q1 17 2.90 M $6.30 M
2021 Q4 20 3.55 M $9.44 M